MedPath

Evaluating the effectiveness of carboxytherapy in decreasing the thickness of abdominal subcutaneous fat through clinical and ultrasonographical studies

Not Applicable
Conditions
The effectiveness of carboxytherapy in reducing the thickness of abdominal subcutaneous fat.
Registration Number
IRCT20220517054900N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

BMI = 25 kg/m2
Waist circumference greater than 102 Cm in men and 88 Cm in women
Waist/Hip ratio greater than 0.9 in men and 0.85 in women
Abdominal sagging

Exclusion Criteria

Pregnancy
Breast feeding
History of smoking, alcohol and drug abuse
Medication (also including supplimentary agents) within 6 weeks before the study initiation
Any lipolytic treatment or procedure at the site of study within one year before the study initiation
Any systemic disorder such as diabetes mellitus, kidney diseases, cardiac diseases, respiratory diseases, liver diseases, severe anemia, etc.
Using diluent and anticonvulsant drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical evaluation objectively and subjectively. Timepoint: Time 0, before each session and 2 weeks after the last session. Method of measurement: Visual and photographic findings.;BMI. Timepoint: Time 0, before each session and two weeks after the last session. Method of measurement: Meters and scales.;Waist circumference. Timepoint: Time 0, before each session and two weeks after the last session. Method of measurement: Meter.;Waist/hip ratio. Timepoint: Time 0, before each session and two weeks after the last session. Method of measurement: Meter.;Abdominal subcutaneous fat thickness and density. Timepoint: 2 weeks after the last session. Method of measurement: Ultrasound machine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath